You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 5, May 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Infectious Diseases
 •Viral Infections
 •Neurology
 •Cognitive Disorders
 •Pathology & Laboratory Medicine
 •Schizophrenia
 •Alert me on articles by topic

Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia

Faith B. Dickerson, PhD; John J. Boronow, MD; Cassie Stallings, RNC; Andrea E. Origoni, BA; Inna Ruslanova, MS; Robert H. Yolken, MD

Arch Gen Psychiatry. 2003;60:466-472.

Background  Cognitive deficits are a characteristic feature of schizophrenia and contribute to the profound disabilities associated with this illness. Some of the cognitive deficits that occur in individuals with schizophrenia are similar to those found in individuals who have recovered from central nervous system infections with human herpesviruses.

Methods  We measured cognitive functioning and serologic evidence of infection with human herpesviruses in 229 outpatients with schizophrenia. We evaluated cognitive functioning with the Repeatable Battery for the Assessment of Neuropsychological Status. For each patient, serum IgG class antibodies with specificities for the following potentially neurotropic human herpesviruses were measured by means of a solid-phase immunoassay: herpes simplex viruses 1 and 2, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and varicella-zoster virus. We determined the association between serologic evidence of herpesviruses infection and cognitive functioning by univariate and multivariate analyses, including demographic and clinical factors associated with cognitive functioning.

Results  We found that serologic evidence of infection with herpes simplex virus 1 is an independent predictor of cognitive dysfunction in individuals with schizophrenia. Discriminant function analysis indicated that much of the difference in cognitive functioning could be attributed to immediate memory. We found no significant association between cognitive dysfunction and serologic evidence of infection with other human herpesviruses.

Conclusion  Serologic evidence of herpes simplex virus 1 infection is associated with cognitive impairment in schizophrenia.


From the Sheppard Pratt Health System (Drs Dickerson and Boronow and Mss Stallings and Origoni) and the Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins School of Medicine (Ms Ruslanova and Dr Yolken), Baltimore, Md.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Selected Infectious Agents and Risk of Schizophrenia Among U.S. Military Personnel
Niebuhr et al.
Am. J. Psychiatry 2008;165:99-106.
ABSTRACT | FULL TEXT  

Deficit Schizophrenia: Association With Serum Antibodies to Cytomegalovirus
Dickerson et al.
Schizophr Bull 2006;32:396-400.
ABSTRACT | FULL TEXT  

[18F]FHPG Positron Emission Tomography for Detection of Herpes Simplex Virus (HSV) in Experimental HSV Encephalitis
Buursma et al.
J. Virol. 2005;79:7721-7727.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.